Clinical Activity and Safety of the ALK/ROS1 TK Inhibitor PF-06463922 in Advanced NSCLCT. M. Bauer,Benjamin J. Solomon,Benjamin Besse,A. Navarro,L. James,J. Clancy,G. Mugundu,J. F. Martini,A. Abbattista,A. ShawJOURNAL OF THORACIC ONCOLOGY（2015）引用 0|浏览21暂无评分关键词ALK,lung cancer,ros1,PF-06463922AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
